Shuji MIZUMOTO, 水本 秀二

About Shuji MIZUMOTO, 水本 秀二

Shuji MIZUMOTO, 水本 秀二, With an exceptional h-index of 35 and a recent h-index of 27 (since 2020), a distinguished researcher at Meijo University, specializes in the field of Glycobiology, genetic disease, proteoglycan, glycosaminoglycan, Ehlers-Danlos syndrome.

His recent articles reflect a diverse array of research interests and contributions to the field:

Global mapping of glycosylation pathways in human-derived cells

Hyaluronan degradation and release of a hyaluronan-aggrecan complex from perineuronal nets in the aged mouse brain

Systematic investigation of the skin in Chst14−/− mice: A model for skin fragility in musculocontractural Ehlers–Danlos syndrome caused by CHST14 variants (mcEDS-CHST14)

Myopathy Associated With Dermatan Sulfate-Deficient Decorin and Myostatin in Musculocontractural Ehlers-Danlos Syndrome: A Mouse Model Investigation

An Overview of in vivo Functions of Chondroitin Sulfate and Dermatan Sulfate Revealed by Their Deficient Mice

Congenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis

A new mouse model of Ehlers-Danlos syndrome generated using CRISPR/Cas9-mediated genomic editing

Memories of Professor Kazuyuki Sugahara

Shuji MIZUMOTO, 水本 秀二 Information

University

Position

Associate Professor

Citations(all)

3970

Citations(since 2020)

2013

Cited By

2767

hIndex(all)

35

hIndex(since 2020)

27

i10Index(all)

72

i10Index(since 2020)

66

Email

University Profile Page

Google Scholar

Shuji MIZUMOTO, 水本 秀二 Skills & Research Interests

Glycobiology

genetic disease

proteoglycan

glycosaminoglycan

Ehlers-Danlos syndrome

Top articles of Shuji MIZUMOTO, 水本 秀二

Global mapping of glycosylation pathways in human-derived cells

Developmental Cell

2021/3/16

Hyaluronan degradation and release of a hyaluronan-aggrecan complex from perineuronal nets in the aged mouse brain

Biochimica et Biophysica Acta (BBA)-General Subjects

2021/2/1

Systematic investigation of the skin in Chst14−/− mice: A model for skin fragility in musculocontractural Ehlers–Danlos syndrome caused by CHST14 variants (mcEDS-CHST14)

Glycobiology

2021/2

Myopathy Associated With Dermatan Sulfate-Deficient Decorin and Myostatin in Musculocontractural Ehlers-Danlos Syndrome: A Mouse Model Investigation

Frontiers in cell and developmental biology

2021

An Overview of in vivo Functions of Chondroitin Sulfate and Dermatan Sulfate Revealed by Their Deficient Mice

2021/1/1

Congenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis

2021

A new mouse model of Ehlers-Danlos syndrome generated using CRISPR/Cas9-mediated genomic editing

Disease Models & Mechanisms

2021/12/1

Memories of Professor Kazuyuki Sugahara

2021/3/25

b3galt6 knock-out zebrafish recapitulate β3GalT6-deficiency disorders in human and reveal a trisaccharide proteoglycan linkage region

Frontiers in cell and developmental biology

2020/12/10

Congenital Disorders Caused by Defects in Catabolism of Glycosaminoglycans

Trends in Glycoscience and Glycotechnology

2020/7

Pseudodiastrophic dysplasia expands the known phenotypic spectrum of defects in proteoglycan biosynthesis

Journal of Medical Genetics

2020/7/1

Delineation of musculocontractural Ehlers–Danlos Syndrome caused by dermatan sulfate epimerase deficiency

Molecular genetics & genomic medicine

2020/5

Congenital Disorders Caused by Defects in Anabolism of Glycosaminoglycans

Trends in Glycoscience and Glycotechnology

2020/3/25

CSGALNACT1‐congenital disorder of glycosylation: A mild skeletal dysplasia with advanced bone age

Human mutation

2020/3

Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome

2020/1

See List of Professors in Shuji MIZUMOTO, 水本 秀二 University(Meijo University)